Abiogen Pharma SpA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Abiogen Pharma SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3399
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イタリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abiogen Pharma SpA (Abiogen), a subsidiary of MDM Holding SpA, is a specialist pharmaceutical company, which develops, manufactures, and markets medicines with focus on musculo-skeletal health, and rare diseases. The company offers products in the form of oral solids, injectables, semi solids, oral liquids, food supplements, and cosmetics for the treatment of hypovitaminosis D, dermatology, bone metabolism, pain and viscosupplementation, respiratory conditions, and diabetes. Abiogen’s service offerings include contract manufacturing, licensing, pharmacovigilance, clinical trial supply, quality assurance, and integrated pharmaceutical development services such as pre-formulation, process optimization and scale-up, clinical manufacturing and technology transfer and validation. The company markets its products through a network of distributors in Italy. Abiogen is headquartered in Pisa, Italy.

Abiogen Pharma SpA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abiogen Pharma SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 10
Licensing Agreements 11
Abiogen Pharma Enters into Licensing Agreement with Lee’s Pharma for Thorens Cholecalciferol 11
Abiogen Pharma Enters into Licensing Agreement with Lee’s Pharma for Attila 12
Grunenthal Enters into Licensing Agreement with Abiogen Pharma 13
Abiogen Pharma SpA – Key Competitors 14
Abiogen Pharma SpA – Key Employees 15
Abiogen Pharma SpA – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Key Facts 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abiogen Pharma SpA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abiogen Pharma SpA, Deals By Therapy Area, 2012 to YTD 2018 8
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Abiogen Pharma Enters Into Distribution Agreement With EffRx For Binosto 10
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Thorens Cholecalciferol 11
Abiogen Pharma Enters into Licensing Agreement with Lee's Pharma for Attila 12
Grunenthal Enters into Licensing Agreement with Abiogen Pharma 13
Abiogen Pharma SpA, Key Competitors 14
Abiogen Pharma SpA, Key Employees 15

List of Figures
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Abiogen Pharma SpA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Abiogen Pharma SpA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mainstream Renewable Power Ltd-エネルギー分野:企業M&A・提携分析
    Summary Mainstream Renewable Power Ltd (Mainstream) develops, finances, constructs, and operates large-scale renewable energy plants. It develops and builds onshore and offshore wind and solar power plants. The company sells the plants to its natural owners including utilities, energy intensive corp …
  • Ajman Bank (AJMANBANK):企業の財務・戦略的SWOT分析
    Ajman Bank (AJMANBANK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Vapotherm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Vapotherm Inc (Vapotherm) is a medical device company that develops and manufactures advanced non-invasive respiratory care devices. The company offers products such as Precision Flow products and accessories, medical-grade vapor, disposable patient circuit, nitric oxide disposable patient c …
  • Silver Fern Farms Limited:企業の戦略的SWOT分析
    Silver Fern Farms Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Vantage Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vantage Oncology Inc (Vantage Oncology), a subsidiary of McKesson Corp is a critical oncology service provider that owns and operates cancer treatment facilities. The company operates cancer treatment facilities in the US. It provides treatment for bone, brain, breast, gastrointestinal, gyne …
  • Emerson Electric Co (EMR):企業の財務・戦略的SWOT分析
    Emerson Electric Co (EMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Edinburgh Molecular Imaging Ltd:企業の製品パイプライン分析2018
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM I …
  • AIA Insurance Lanka Plc (CTCE.N0000):企業の財務・戦略的SWOT分析
    AIA Insurance Lanka Plc (CTCE.N0000) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Arrow Electronics Inc (ARW):企業の財務・戦略的SWOT分析
    Arrow Electronics Inc (ARW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Norton Healthcare Inc-製薬・医療分野:企業M&A・提携分析
    Summary Norton Healthcare Inc (Norton Healthcare) is a healthcare service provider that offers medical services. The center offers services such as cancer care, bariatric and weight management, diabetes and endocrine, gastroenterology, clinical trials, pain management, bone marrow transplantation, d …
  • University of Dundee-製薬・医療分野:企業M&A・提携分析
    Summary University of Dundee (Dundee) is an educational research university that offers a range of undergraduate, postgraduate, postgraduate research degree, distant learning and English language programs. The university offers a wide range of academic and research courses in various disciplines suc …
  • Presidio Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Presidio Pharmaceuticals Inc (Presidio) is a clinical-stage pharmaceutical company that discovers and develops small-molecule antiviral therapeutics. The company’s products include HCV NS5A, NS5B proteins, lead pan-genotypic HCV NS5A inhibitor, ravidasvir hydrochloride, protease inhibitor, f …
  • Terumo Corporation:企業の戦略・SWOT・財務分析
    Terumo Corporation - Strategy, SWOT and Corporate Finance Report Summary Terumo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • CMA CGM SA:企業の戦略・SWOT・財務情報
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Samsung Heavy Industries Co., Ltd.:企業の戦略・SWOT・財務分析
    Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Samsung Heavy Industries Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Dominium S.A.:企業の戦略・SWOT・財務情報
    Dominium S.A. - Strategy, SWOT and Corporate Finance Report Summary Dominium S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Sekisui Chemical Co Ltd (4204):企業の財務・戦略的SWOT分析
    Sekisui Chemical Co Ltd (4204) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Metabolon Inc:医療機器:M&Aディール及び事業提携情報
    Summary Metabolon Inc (Metabolon) is a health technology company that develops clinical diagnostic tests for healthcare markets. The company’s products include non-alcoholic steatohepatitis test, GFR test, quantose IGT test, prostarix and prostarix plus tests, among others. Its quantose IR test is a …
  • Lightbridge Corporation (LTBR):企業の財務・戦略的SWOT分析
    Lightbridge Corporation (LTBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Panasonic Corporation (6752):企業の財務・戦略的SWOT分析
    Panasonic Corporation (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆